Skip to main content

TB Education, Training and Resources

Training Materials

Document Number Title Revision Date
TB-905 Tuberculin Skin Test Competency Check List 9/2024
13-14599 Venipuncture Performance Evaluation 4/2015

 

Brown Bag

Title Revision Date
Drug-Resistant TB in Texas - Tools for Success 4/2023
Therapeutic Drug Monitoring: A Tool for Case Management 12/2018
TB Public Health Follow-Up Tools and Case Studies 8/2018
Tuberculosis Targeted Testing 6/2018
Outpatient Case Management of Drug-Resistant TB 4/2018
TB GIMS 2/2018

 

Fact Sheets

Document Number Title Revision Date
  What Tuberculosis Clinicians Should Know About Nitrosamines 4/2022
TB-915 Take on TB 10/2020
  1 2 3s of TB 3/2020
13-13692 TB in Texas 4/2020
13-15777 Tuberculosis Along the Texas-Mexico Border 1/2021
TB-416 Tuberculosis Among Texans Experiencing Homelessness (English) 10/2018
TB-416a Tuberculosis Among Texans Experiencing Homelessness (Spanish) 10/2018

 

CDC Resource Documents

TB Guidelines – From CDC Division of TB Elimination, a listing of all TB guidelines issued from the division

Recommendations for Use of Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection – From CDC MMWR Weekly: December 9, 2011; 60 (48); 1650-1653

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium Tuberculosis Infection - United States, 2010 – From CDC MMWR Recommendations and Reports; June 25, 2010; 59 (RR-05); 1-25

Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis – From CDC MMWR Weekly; January 16, 2009, 58 (01); 7-10

Plan to Combat Extensively Drug-Resistant Tuberculosis – From CDC MMWR Recommendations and Reports; February 13, 2009; 58 (RR-03); 1-43

Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC – From CDC MMWR Recommendations Reports; July 7, 2006; 55 (RR-09); 1-44

Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States – From CDC MMWR Recommendations and Reports; December 16, 2005; 54 (No. RR-15); 49-55

Controlling Tuberculosis in the United States - Recommendations from the American Thoracic Society, CDC, and the Infectious Disease Society of America – From CDC MMWR Weekly; November 4, 2005; 54 (RR-12); 1-81

Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 – From CDC MMWR Recommendations and Reports; December 30, 2005; 54 (RR-17); 1-141

Treatment of Tuberculosis – American Thoracic Society, CDC, and Infectious Diseases Society of America MMWR; June 20, 2003; 52 (RR-11); 1-77

Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States: Recommendations of the Advisory Council for the Elimination of Tuberculosis – From CDC MMWR Recommendations and Reports; May 3, 2002; 51 (RR-05); 1- 16

Tuberculosis Technical Instruction for Panel Physicians